ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025
Laryngeal Neuroendocrine Carcinoma.
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neuroendocrine tumours of the larynx are extremely rare, though they make up only 1% of tumours in this region with the most common site being the supraglottis. On exhaustive research on PubMed, there are only a few prior cases of neuroendocrine carcinoma of subglottis published in the literature. Case Report: A 56-year-old male presented to our center with complaints of hoarseness and dyspnoea for 1 month which was insidious in onset and gradually progressive. The patient was evaluated and diagnosed with as subglottic mass. He underwent tracheostomy followed by Micro laryngoscopy and Biopsy under GA. Post-op HPE report s/o Neuroendocrine carcinoma- small cell type. On evaluation no second primary or distant metastatic site was identified. Conclusion: Small cell neuroendocrine carcinoma of the subglottic larynx is an exceptionally rare and aggressive malignancy. Its presentation can be atypical, such as with symptoms of stridor, necessitating a high index of clinical suspicion. Early diagnosis and prompt, aggressive management are critical for improving outcomes. Despite the limited prognosis associated with this type of cancer, the patient in this case has shown a favourable response to chemoradiotherapy. Continued monitoring is essential due to the high risk of recurrence and metastasis associated with this malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.